申请人:Schering Corporation and Pharmacopeia, Inc.
公开号:US20040147559A1
公开(公告)日:2004-07-29
There are disclosed compounds of the formula
1
or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
这里公开了用于治疗诸如急性和慢性炎症性疾病以及癌症的趋化因子介导疾病的公式1化合物或其药用可接受的盐或溶剂。